ALYSSA D'LUGIN: Open Payments
NPI 1184355919 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$985 in 46 payments from 10 companies in 2025. Trend: 2023 $238 · 2024 $17 · 2025 $985
Food & beverage: $985
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 16 | $291 |
| Valinor Pharma, LLC | 9 | $172 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $170 |
| Forte Bio-Pharma LLC | 6 | $135 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $92 |
| SCILEX PHARMACEUTICALS INC. | 2 | $34 |
| Tonix Medicines, Inc. | 2 | $33 |
| Indivior Inc. | 1 | $21 |
| Braeburn Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: Belbuca, MOVANTIK, JOURNAVX, PROLATE, RELISTOR, ZTLido, TONMYA, XTAMPZA.
Industry payments across NC — which companies pay providers there.
